Cancer Research at MSKCC
Fund raising is important, but results are critical
Participants in the Terry Fox Run deserve to know how their hard earned contributions impact the field of cancer research. To this end, we are very pleased to report that the research conducted at Memorial Sloan Kettering Cancer Center by Dr. Renier Brentjens directly supported by contributions raised by the Terry Fox Run has recently yielded very promising clinical results in patients with B cell cancers. Specifically, the work pioneered at MSKCC and adapted at other cancer centers using gene therapy techniques to stimulate the immune system to kill tumor cells has resulted in profoundly promising results in patients with advanced B cell cancers including non-Hodgkins lymphomas, chronic lymphocytic leukemias, and acute lymphoblastic leukemias.
While the numbers of patients at this time remains relatively small, and caution interpreting these results is warranted, the enthusiasm for this gene therapy approach to treating cancer is certainly very well warranted. The hard working volunteers and participants of the annual Terry Fox Run in New York should be congratulated as we are making a very real difference in the lives of cancer patients. We are certainly providing hope and perhaps ultimately a cure. The investigators at MSKCC and Dr Brentjens in particular express their heartfelt thanks for making this possible, and for keeping your faith in their work. For more information regarding Dr Brentjens' work, please click on the links below.
World News With Diane Sawyer